Logo
  • Real Estate
  • Personal Finance
  • Health & Wellness
  • Financials
  • DMCA
  • About Us
  • Terms of Service
  • Privacy Policy
©2021 Market Realist. All rights reserved.

Biohaven Pharmaceutical Holding Company Ltd

Most Recent

  • uploads///Chart
    Company & Industry Overviews

    Insys Therapeutics: Recommendations and Market Capitalization

    Wall Street analysts estimate that INSY stock could decrease ~3% over the next 12 months. That show a 12-month target price of $9.60.

    By Mike BensonOct. 5 2018, Published 10:08 a.m. ET
Do Not Sell My Personal Information